Two Sigma Securities, LLC Biond Vax Pharmaceuticals Ltd. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.16 - $1.88 $26,589 - $43,093
-22,922 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.15 - $2.34 $30,495 - $62,052
-26,518 Reduced 53.64%
22,922 $38,000
Q4 2021

Feb 14, 2022
BUY
$1.48 - $2.92 $73,171 - $144,364
49,440 New
49,440 $116,000

About BiondVax Pharmaceuticals Ltd.

BVXV Quotes by TradingView
  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email